The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSMD.L Regulatory News (SMD)

  • There is currently no data for SMD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Burn Image Assessment Study (“BIAS”) Results

5 Oct 2022 07:00

RNS Number : 7596B
Spectral MD Holdings, Ltd.
05 October 2022
 

Spectral MD Holdings, Ltd

("Spectral MD" or the "Company")

 

Burn Image Assessment Study ("BIAS") Results

Study assesses Emergency Medicine Physicians' ability to measure burn depth

 

LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces results from its Burn Image Assessment Study (BIAS).

 

Over one million people in the US and 250,000 in the UK seek evaluation for burn injuries in emergent or urgent care settings every year. A major component of the initial evaluation includes burn wound assessment. Literature shows that burn care providers typically assess the depth of burn wounds incorrectly in about 25-30% of injuries, partly because burn wound evaluation has no adjunctive labs to aid in the determination of healing versus non-healing burn wounds.

 

The objective of the Burn Injury Assessment Study (BIAS) is to obtain data in assessment of burn depth by experts across the spectrum of Emergency Medicine (EM) providers. BIAS collected data from emergency room providers at national conferences. Using a tablet-based data entry device, emergency medicine participants enrolled in the study completed a brief questionnaire followed by a series of five scenarios of thermal burn injuries each with images from American Burn Association (ABA)-verified burn centers. Participants were asked to provide an overall treatment recommendation for each burn scenario. In addition, they were asked to draw the regions of non-healing burn wound areas within the provided images. Their performance was evaluated by comparing their drawings with healing/non-healing areas pre-established by burn expert review of each burns' 21-day healing assessment.

 

Dr. Jeff Carter, Chief Medical Consultant of Spectral MD, and Treasurer of the American Burn Association presented the results in a podium presentation titled, "Results from the Emergency Medicine Burn Injury Assessment Study" at the American College of Emergency Physicians Scientific Assembly on 2 October, 2022.

 

The results from this study indicated that in reviewing pictures of burn wounds that were so severe they would not have healed, emergency department (ED) practitioners selected that no surgery was needed and advised treatment with local wound care in 82% of patients. This would have resulted in surgical delays in four out of five patients. For healing wounds, ED practitioners selected local wound care in only 31% of the images. When matched pixel for pixel, ED practitioners had an accuracy of 74%, meaning that about a quarter of the wounds were inaccurately assessed. This is well below the current performance of Spectral MD's DeepView™ Wound Imaging System.

 

Dr. Jeff Carter stated: "It is surprising to find that 31% of clinical judgment suggested that surgery or referral was necessary for burns that would actually heal with local wound care, which leads to unnecessary surgery and waste of resources."

 

This study emphasizes the unmet clinical need for technologies which can improve evaluation of burn wound healing. In a natural disaster or mass casualty incident, large numbers of burn casualties could overwhelm an already strained healthcare system, and EM providers would be called upon to perform large volumes of burn wound assessment. Improvements in evaluating burn wound healing are essential to aid emergency room providers in the appropriate treatment of burn-injured patients. The BIAS results further support the Company's belief that the DeepView™ Wound Imaging System will be transformative in improving the current standard of care, resulting in faster application of advanced therapy, better wound healing, and meaningful clinical outcomes.

 

This project has been supported in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), under contract number 75A50119C00033.

 

Learn more about BARDA: https://www.medicalcountermeasures.gov/

 

Funding support for DeepView®'s use in burn triage and treatment decisions has also been provided by U.S. National Science Foundation (NSF), U.S. National Institutes of Health (NIH) and U.S. Defense Health Agency (DHA).

 

For further information please contact:

 

Spectral MD Holdings, Ltd.

investors.spectralmd.com

Wensheng Fan, Chief Executive Officer

via Walbrook PR

Nils Windler, Chief Financial Officer

 

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com

Paul McManus / Louis Ashe-Jepson

Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393

+44 (0)7407 804 654

 

About Spectral MD:

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.

www.spectralmd.com

info@spectralmd.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFSSIRLSIIF
12
Date   Source Headline
7th Sep 20232:22 pmRNSResult of Rosecliff Special Meeting - Correction
7th Sep 202311:36 amRNSResult of Rosecliff Special Meeting
31st Aug 20234:35 pmRNSResult of General Meeting
25th Aug 20237:00 amRNSExercise of Options
17th Aug 20235:01 pmRNSPosting of Circular and Notice of General Meeting
16th Aug 20231:00 pmRNSInvestor Video Published
14th Aug 202311:30 amRNSProxy Statement & Prospectus Mailed by Rosecliff
14th Aug 20237:00 amRNSISO 13485 Certification Received
11th Aug 20234:10 pmRNSUpdated Form S-4 Filing & Investor Presentation
9th Aug 20234:05 pmRNSUpdated Form S-4 Filed by Rosecliff
9th Aug 20232:50 pmRNSProposed AIM Cancellation
1st Aug 20237:01 amRNSForm 8-K Filed by Rosecliff
1st Aug 20237:00 amRNSUpdated Investor Presentation & Rosecliff Filing
28th Jul 202312:58 pmRNSUpdated Form S-4 Filed by Rosecliff
28th Jun 20237:00 amRNSUpdated Form S-4 Filed by Rosecliff
22nd Jun 20237:00 amRNSNew Investor Presentation & Filing by Rosecliff
20th Jun 20237:00 amRNSISO 13485 Certification Audit Completed
13th Jun 20237:00 amRNSStudy Results Published in Peer-Reviewed Journal
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
2nd May 20231:06 pmRNSFiling of Form S-4 by Rosecliff
19th Apr 20237:00 amRNSForm 8-K Filed by Rosecliff Acquisition Corp I
18th Apr 20237:00 amRNS$4.0 Million Grant Award from the MTEC
13th Apr 20237:00 amRNSGrant of Options
11th Apr 20237:00 amRNSBusiness Combination Agreement
29th Mar 20237:00 amRNSPublication of Annual Financial Report
27th Mar 20237:00 amRNSU.S. Burn AI Training Study Enrollment Completed
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
27th Feb 20237:00 amRNSFinal Results
21st Feb 20237:00 amRNSEU Clinical Study Initiated
14th Feb 202310:18 amRNSNotice of Results
3rd Feb 20234:24 pmRNSTotal Voting Rights
18th Jan 20237:00 amRNSDFU Clinical Study Interim Results & Burn Update
16th Jan 20237:00 amRNSTrading Update
9th Nov 20227:00 amRNSAppointment of Chief Operating Officer
7th Nov 20227:00 amRNSBlock Admission
2nd Nov 20227:00 amRNSTrading Update
24th Oct 20227:00 amRNSChanges to Board of Directors
12th Oct 20223:26 pmRNSExercise of Options
5th Oct 20227:00 amRNSBurn Image Assessment Study (“BIAS”) Results
27th Sep 20225:59 pmRNSResult of AGM
20th Sep 20227:00 amRNSInterim results for the six-months to 30 June 2022
12th Sep 20221:00 pmRNSChange of Interim Results Date
5th Sep 20227:00 amRNSNotice of results
1st Sep 20227:00 amRNSNotice of AGM
30th Aug 20227:00 amRNSAdditional $8.2M of Funding from BARDA
19th Aug 20229:13 amRNSGrant of Options
7th Jul 20227:00 amRNSStockholder waiver granted
23rd Jun 20227:00 amRNSRemoval of Regulation S restrictions
17th Jun 202210:40 amRNSMediscience Award Win
13th Jun 20227:00 amRNSInitiation of DFU Validation Study
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.